Andere Sprachen IPH Limited

Aktien

Verzögert Australian S.E. Andere Börsenplätze 06:58:34 29.05.2024			% 5 Tage	% 1. Jan.
6,06 ^AUD	-2,26 %		-2,10 %	-5,46 %

10.05.	Adamantem Capital triumphiert über IPH im QANTM Bieterkrieg	MT
08.05.	IPH unterbreitet Vorschlag zur Übernahme von QANTM Intellectual Property	MT

IPH Extends Share Repurchase Program	13.05.
Adamantem Capital Triumphs Over IPH in QANTM Bidding War	10.05.
IPH Submits Proposal to Acquire QANTM Intellectual Property	08.05.
IPH Joins QANTM Bidding War; QANTM Shares Up 6%	08.05.
IPH Limited entered into non-binding indicative proposal to acquire QANTM Intellectual Property Limited for AUD 250 million.	08.05.
IPH Limited Announces Executive Changes	29.02.
IPH Managing Director Pares Shareholding in Firm	28.02.
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	21.02.
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	21.02.
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21.02.
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	04.01.
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	19.12.
IPH Completes ROBIC Business Acquisition	18.12.
IPH Limited completed the acquisition of ROBIC L.L.P.	15.12.
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	22.11.
IPH Managing Director and CEO Sells Company Shares	22.11.
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	20.11.
IPH Limited Approves Election of Director, David Wiadrowski	15.11.
IPH Limited Seeks Acquisitions	15.11.
IPH Completes AU$75 Million Acquisition of Canadian IP Services Firm	02.10.23

Keine Ergebnisse zu dieser Suche